SciELO - Scientific Electronic Library Online

 
vol.20 número4Errores de medición en la interpretación mamográfica por radiólogosModos de vida y estado de salud de migrantes en un asentamiento de Barranquilla, 2018 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista de Salud Pública

versión impresa ISSN 0124-0064

Resumen

DA GRACA SALOMAO, Maria; DE OLIVEIRA LUNA, Karla Patricia  y  MACHADO, Claudio. Epidemiology of accidents by venomous animals and distribution of antivenon: state of art and world status. Rev. salud pública [online]. 2018, vol.20, n.4, pp.523-529. ISSN 0124-0064.  https://doi.org/10.15446/rsap.v20n4.70432.

Accidents by venomous animals are discussed under the historical perspective of state actions. Considered as neglected diseases, they cause social and economic losses in the working age population from rural areas of poor countries, as few of them have public health policies for adequate prophylaxis and treatment; in fact, the largest life losses occur in Africa and Asia. The 46 world producers of antivenin do not meet the global needs, making access to treatment difficult, even in countries with own production. Notification systems lead to inaccurate surveillance surveys and antivenin needs. Despite mandatory notification, Brazil lacks robust databases with full open access in order to allow the timely distribution of antivenin for quality care of these patients. Progress has been made in diagnostic testing, but its application in poor areas is not feasible due to high costs. Improvements in quality antivenin production through good laboratory practices and manufacturing minimize unsatisfactory results of treatments carried out with products of dubious origin. Antivenin development using biotechnology and well-designed clinical trials are key for the treatment of envenoming by agents phylogenetically related from different regions (continental or universal antivenins). International partnerships are fundamental, besides regulatory stocks, similarly to those adopted for vaccines, to supply world demand. The qualification of antivenin will certainly minimize treatment mistakes. Government support to research is a driving force and the most efficient tool for preserving life and avoiding social security surcharges, particularly in developing countries.

Palabras clave : Poisonous animals; serum; technological development; public health policy (source: MeSH, NLM).

        · resumen en Español | Portugués     · texto en Portugués     · Portugués ( pdf )